Skip to main content
. Author manuscript; available in PMC: 2021 Dec 25.
Published in final edited form as: Sci Immunol. 2021 Jun 25;6(60):eabg4176. doi: 10.1126/sciimmunol.abg4176

Figure 6: CD36-blockade facilitated ex vivo analysis of type II NKT cells and GEM-T cells.

Figure 6:

A. FACS plots from 3 healthy donor PBMC samples (representative of a cohort of 8) showing CD1d tetramer staining on lymphocytes with and without CD36-blockade. B. FACS plots from 3 healthy donor PBMC samples showing CD1b-GMM tetramer staining on CD4+ T cells with and without CD36-blockade.